GB9819826D0 - Gene therapy method - Google Patents

Gene therapy method

Info

Publication number
GB9819826D0
GB9819826D0 GBGB9819826.0A GB9819826A GB9819826D0 GB 9819826 D0 GB9819826 D0 GB 9819826D0 GB 9819826 A GB9819826 A GB 9819826A GB 9819826 D0 GB9819826 D0 GB 9819826D0
Authority
GB
United Kingdom
Prior art keywords
gene therapy
therapy method
gene
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819826.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9819826.0A priority Critical patent/GB9819826D0/en
Publication of GB9819826D0 publication Critical patent/GB9819826D0/en
Priority to JP2000559235A priority patent/JP2002520020A/en
Priority to IL14053399A priority patent/IL140533A0/en
Priority to CN99810616A priority patent/CN1317045A/en
Priority to PCT/GB1999/002199 priority patent/WO2000003014A1/en
Priority to HU0102835A priority patent/HUP0102835A3/en
Priority to EEP200100020A priority patent/EE200100020A/en
Priority to BR9912018-6A priority patent/BR9912018A/en
Priority to APAP/P/2001/002038A priority patent/AP2001002038A0/en
Priority to AU47914/99A priority patent/AU763713B2/en
Priority to CA002336805A priority patent/CA2336805A1/en
Priority to EP99931378A priority patent/EP1097200A1/en
Priority to PL99345507A priority patent/PL345507A1/en
Priority to EA200100028A priority patent/EA200100028A1/en
Priority to YU1901A priority patent/YU1901A/en
Priority to TR2001/00622T priority patent/TR200100622T2/en
Priority to SK38-2001A priority patent/SK382001A3/en
Priority to KR1020017000413A priority patent/KR20010071832A/en
Priority to NZ509174A priority patent/NZ509174A/en
Priority to IDW20010345A priority patent/ID27742A/en
Priority to IS5788A priority patent/IS5788A/en
Priority to NO20010166A priority patent/NO20010166L/en
Priority to HR20010025A priority patent/HRP20010025A2/en
Ceased legal-status Critical Current

Links

GBGB9819826.0A 1998-07-11 1998-09-12 Gene therapy method Ceased GB9819826D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
IDW20010345A ID27742A (en) 1998-07-11 1999-07-09 PHARMACEUTICAL USE OF NAB1 AND NAB2
CA002336805A CA2336805A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
PL99345507A PL345507A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
CN99810616A CN1317045A (en) 1998-07-11 1999-07-09 Pharmaceutical uses of NAB1 and NAB2
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
HU0102835A HUP0102835A3 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
EEP200100020A EE200100020A (en) 1998-07-11 1999-07-09 Pharmaceutical Use of NAB1 and NAB2
BR9912018-6A BR9912018A (en) 1998-07-11 1999-07-09 Use of a nucleic acid molecule, nucleic acid molecule, pharmaceutical composition, method of treating cell proliferation disorders associated with wound healing in a mammal, including humans, and use of a nab1 or nab2 polypeptide
APAP/P/2001/002038A AP2001002038A0 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of NAB1 and NAB2.
AU47914/99A AU763713B2 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of NAB1 and NAB2
JP2000559235A JP2002520020A (en) 1998-07-11 1999-07-09 Use of NAB1 and NAB2 as drugs
EP99931378A EP1097200A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
IL14053399A IL140533A0 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
EA200100028A EA200100028A1 (en) 1998-07-11 1999-07-09 PHARMACEUTICAL APPLICATIONS NAB1 AND NAB2
YU1901A YU1901A (en) 1998-07-11 1999-07-09 Pharmaceutical uses for nab1 and nab2
TR2001/00622T TR200100622T2 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of NAB1 and NAB2
SK38-2001A SK382001A3 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2
KR1020017000413A KR20010071832A (en) 1998-07-11 1999-07-09 Pharmaceutical Uses of NAB1 and NAB2
NZ509174A NZ509174A (en) 1998-07-11 1999-07-09 Use of polynucleotides encoding NAB1 and NAB2 in wound healing
IS5788A IS5788A (en) 1998-07-11 2000-12-22 Pharmacological use of NAB1 and NAB2
NO20010166A NO20010166L (en) 1998-07-11 2001-01-10 Pharmaceutical applications of NAB1 and NAB2
HR20010025A HRP20010025A2 (en) 1998-07-11 2001-01-11 Pharmaceutical uses of nab1 and nab2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method

Publications (1)

Publication Number Publication Date
GB9819826D0 true GB9819826D0 (en) 1998-11-04

Family

ID=10838713

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819826.0A Ceased GB9819826D0 (en) 1998-07-11 1998-09-12 Gene therapy method

Country Status (1)

Country Link
GB (1) GB9819826D0 (en)

Similar Documents

Publication Publication Date Title
GB9622500D0 (en) Therapeutic gene
EP1077996A4 (en) HUMAN EDG3sb GENE
HUP0103252A3 (en) Gene therapy method
GB9816556D0 (en) Therapy
HUP0104046A3 (en) Adenovirus-mediated gene therapy
GB9719161D0 (en) New therapeutic method
GB9714841D0 (en) Treatment method
GB9819764D0 (en) Method
GB9924981D0 (en) Gene therapy
GB9900009D0 (en) Gene therapy
GB9926144D0 (en) Method
GB9819846D0 (en) Gene therapy method
GB9819826D0 (en) Gene therapy method
GB9815035D0 (en) Gene therapy method
GB9814989D0 (en) Gene therapy method
GB9811836D0 (en) Gene therapy method
GB9706469D0 (en) Genetic method
GB0406539D0 (en) Gene therapy
GB9820185D0 (en) Method
GB9719176D0 (en) New therapeutic method
GB9719189D0 (en) New therapeutic method
GB9800683D0 (en) Therapeutic method
GB9804285D0 (en) Therapeutic method
GB9806039D0 (en) Therapy
GB9818001D0 (en) Genetic method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)